CELL RECEPTOR DEVELOPS A FUTURE-ORIENTED THERAPY FOR HIGH MEDICAL NEEDS: CANCER AND AUTOIMMUNE DISEASES
Cell Receptor is a burgeoning Geneva-based corporation that has made groundbreaking strides in cancer treatment and autoimmune diseases with promising approaches.
Traditionally, oncology is based on the assumption that cancer cells autonomously regulate their growth. Therefore, existing treatments aim to directly kill the tumour cells while causing as minor damage as possible to other cells. Unfortunately, these methods are often associated with severe side effects that can be distressing for patients.
However, Cell Receptor has developed a completely new approach that could revolutionise cancer treatment. We have discovered a mechanism that blocks the growth of tumour cells by attacking the signalling from outside the cell. Our innovative approach targets the receptors on the surface of cancer cells to prevent their growth. This makes our method unique because it works without harmful side effects.
Every growing cell, including tumour cells, requires platelets to divide. These platelets supply the cells with growth factors and help them escape the immune system. They also protect circulating tumour cells from shear forces. We have discovered how to block this contact to prevent the growth of tumour cells and especially metastasis. Thus, we have met an urgent need.
See this article: https://www.nature.com/articles/d43747-021-00133-8